{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T04:11:37Z","timestamp":1751947897459,"version":"3.41.2"},"posted":{"date-parts":[[2025,4,24]]},"group-title":"In Review","reference-count":56,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,2,4]]},"abstract":"<title>Abstract<\/title>\n        <p>Barth syndrome is an X-linked syndrome characterized by cardiomyopathy, skeletal myopathy, and neutropenia. This life-threatening disorder results from loss-of-function mutations in <italic>TAFAZZIN<\/italic>, which encodes a phospholipid-lysophospholipid transacylase located in the mitochondria inner membrane. Decreased cardiolipin levels and increased monolysocardiolipin levels perturb mitochondrial function. However, the mechanism(s) leading to myopathies and neutropenia are unknown, and no currently effective therapy exists. To address these knowledge gaps, we generated <italic>tafazzin<\/italic>-deficient zebrafish. Neutropenia developed 5 days post-fertilization, but surprisingly no cardiac or skeletal myopathies were detected into adulthood. <italic>tafazzin<\/italic> mutants displayed multiple metabolic disturbances like those observed in humans with Barth syndrome. These include increased monolysocardiolipin: cardiolipin ratios, high levels of 3-methylglutaconic acid, decreased ATP production, increased levels of lactic acid, and hypoglycemia. There were also widespread effects on amino acid and unsaturated fatty acid synthesis. Despite these metabolic disturbances, zebrafish displayed a normal lifespan and fertility. Cardiolipin abnormalities were detected in both larvae and adult tissues, specifically in the heart and whole kidney marrow. Surprisingly, adult <italic>tafazzin<\/italic> mutants exhibited a higher number of neutrophils compared to wildtype fish. Further investigation revealed signs of inflammation as evidenced by elevated levels of <italic>il6 <\/italic>in the whole kidney marrows and hearts of adult fish. Our comprehensive studies demonstrated that while mitochondrial dysfunction and metabolic defects were evident in <italic>tafazzin<\/italic>-deficient zebrafish, these disturbances did not significantly affect their development nor survival. These findings suggest that zebrafish may possess salvage pathways which compensate for Tafazzin loss or that humans have a unique vulnerability to the loss of TAFAZZIN.<\/p>","DOI":"10.21203\/rs.3.rs-5960642\/v1","type":"posted-content","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T19:59:26Z","timestamp":1745524766000},"source":"Crossref","is-referenced-by-count":0,"title":["Tafazzin-Deficient Zebrafish Display Mitochondrial Dysfunction, Neutropenia, and Metabolic Defects Without Myopathy"],"prefix":"10.21203","author":[{"given":"Usua","family":"Oyarbide","sequence":"first","affiliation":[{"name":"Cleveland Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca A.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Cleveland Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Radzikh","sequence":"additional","affiliation":[{"name":"Cleveland State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillian V.","family":"Kodger","sequence":"additional","affiliation":[{"name":"Cleveland State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay S.","family":"Patil","sequence":"additional","affiliation":[{"name":"Cleveland State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgan","family":"Staton","sequence":"additional","affiliation":[{"name":"Cleveland State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anny","family":"Mulya","sequence":"additional","affiliation":[{"name":"Cleveland Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevieve M.","family":"Crane","sequence":"additional","affiliation":[{"name":"Cleveland Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Litovsky","sequence":"additional","affiliation":[{"name":"University of Alabama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yana","family":"Sandlers","sequence":"additional","affiliation":[{"name":"Cleveland State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth J.","family":"Corey","sequence":"additional","affiliation":[{"name":"Cleveland Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0022-510x(83)90209-5","article-title":"An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes","volume":"62","author":"Barth PG","year":"1983","unstructured":"Barth, P. G. et al. An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. J. Neurol. Sci. 62, 327\u2013355. 10.1016\/0022-510x(83)90209-5 (1983).","journal-title":"J. Neurol. Sci."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2667","author":"Spencer CT","year":"2006","unstructured":"Spencer, C. T. et al. Cardiac and clinical phenotype in Barth syndrome. Pediatrics 118, e337-346, (2006). 10.1542\/peds.2005-2667"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jdb8020010","article-title":"Role of Tafazzin in Mitochondrial Function, Development and Disease","volume":"8","author":"Chin MT","year":"2020","unstructured":"Chin, M. T. & Conway, S. J. Role of Tafazzin in Mitochondrial Function, Development and Disease. J. Dev. biology. 8 10.3390\/jdb8020010 (2020).","journal-title":"J. Dev. biology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102333","article-title":"Tafazzin Mutation Affecting Cardiolipin Leads to Increased Mitochondrial Superoxide Anions and Mitophagy Inhibition in Barth Syndrome","volume":"9","author":"Petit PX","year":"2020","unstructured":"Petit, P. X., Ardilla-Osorio, H., Penalvia, L. & Rainey, N. E. Tafazzin Mutation Affecting Cardiolipin Leads to Increased Mitochondrial Superoxide Anions and Mitophagy Inhibition in Barth Syndrome. Cells 9 10.3390\/cells9102333 (2020).","journal-title":"Cells"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/jimd.12422","article-title":"Clinical presentation and natural history of Barth Syndrome: An overview","volume":"45","author":"Taylor C","year":"2022","unstructured":"Taylor, C. et al. Clinical presentation and natural history of Barth Syndrome: An overview. J. Inherit. Metab. Dis. 45, 7\u201316. 10.1002\/jimd.12422 (2022).","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.29245\/2572-9411\/2017\/2.1087","article-title":"Barth syndrome: A life-threatening disorder caused by abnormal cardiolipin remodeling","volume":"2","author":"Raja V","year":"2017","unstructured":"Raja, V., Reynolds, C. A. & Greenberg, M. L. Barth syndrome: A life-threatening disorder caused by abnormal cardiolipin remodeling. J. Rare Dis. Res. Treat. 2, 58\u201362. 10.29245\/2572-9411\/2017\/2.1087 (2017).","journal-title":"J. Rare Dis. Res. Treat."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jpeds.2019.09.074","article-title":"L. A Bayesian Analysis to Determine the Prevalence of Barth Syndrome in the Pediatric Population","volume":"217","author":"Miller PC","year":"2020","unstructured":"Miller, P. C., Ren, M., Schlame, M., Toth, M. J. & Phoon, C. K. L. A Bayesian Analysis to Determine the Prevalence of Barth Syndrome in the Pediatric Population. J. Pediatr. 217, 139\u2013144. 10.1016\/j.jpeds.2019.09.074 (2020).","journal-title":"J. Pediatr."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-123680","author":"Sohn J","year":"2019","unstructured":"Sohn, J., Brouse, T., Aziz, N. & Sykes, D. B. What Links Neutropenia to Immature Cardiolipin in Patients with Barth Syndrome (tafazzin-deficiency)? Blood 134, 3579\u20133579, (2019). 10.1182\/blood-2019-123680"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ehf2.12588","article-title":"Late diagnosis of Barth syndrome in a 39-year-old patient with non-compaction cardiomyopathy and neutropenia","volume":"7","author":"Seitz A","year":"2020","unstructured":"Seitz, A., Hinck, A., Bekeredjian, R. & Sechtem, U. Late diagnosis of Barth syndrome in a 39-year-old patient with non-compaction cardiomyopathy and neutropenia. ESC Heart Fail. 7, 697\u2013701. 10.1002\/ehf2.12588 (2020).","journal-title":"ESC Heart Fail."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"ytab195","DOI":"10.1093\/ehjcr\/ytab195","article-title":"Case report of Barth syndrome: a forgotten cause of cardiomyopathy","volume":"5","author":"Rao S","year":"2021","unstructured":"Rao, S., Kanwal, A. & Padmanabhan, S. Case report of Barth syndrome: a forgotten cause of cardiomyopathy. Eur. Heart J. Case Rep. 5, ytab195. 10.1093\/ehjcr\/ytab195 (2021).","journal-title":"Eur. Heart J. Case Rep."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1750-1172-8-23","article-title":"Barth syndrome","volume":"8","author":"Clarke SL","year":"2013","unstructured":"Clarke, S. L. et al. Barth syndrome. Orphanet J. Rare Dis. 8, 23. 10.1186\/1750-1172-8-23 (2013).","journal-title":"Orphanet J. Rare Dis."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/labinvest.3700480","article-title":"Comparison of lymphoblast mitochondria from normal subjects and patients with Barth syndrome using electron microscopic tomography","volume":"87","author":"Acehan D","year":"2007","unstructured":"Acehan, D., Xu, Y., Stokes, D. L. & Schlame, M. Comparison of lymphoblast mitochondria from normal subjects and patients with Barth syndrome using electron microscopic tomography. Lab. Invest. 87, 40\u201348. 10.1038\/labinvest.3700480 (2007).","journal-title":"Lab. Invest."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.bbamem.2017.03.013","article-title":"Cardiolipin and mitochondrial cristae organization","volume":"1859","author":"Ikon N","year":"2017","unstructured":"Ikon, N. & Ryan, R. O. Cardiolipin and mitochondrial cristae organization. Biochim. et Biophys. acta Biomembr. 1859, 1156\u20131163. 10.1016\/j.bbamem.2017.03.013 (2017).","journal-title":"Biochim. et Biophys. acta Biomembr."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"165803","DOI":"10.1016\/j.bbadis.2020.165803","article-title":"Cardiolipin remodeling in Barth syndrome and other hereditary cardiomyopathies","volume":"1866","author":"Bertero E","year":"2020","unstructured":"Bertero, E., Kutschka, I., Maack, C. & Dudek, J. Cardiolipin remodeling in Barth syndrome and other hereditary cardiomyopathies. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165803. 10.1016\/j.bbadis.2020.165803 (2020).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"30360","DOI":"10.1074\/jbc.M109.048322","article-title":"Identification of the human mitochondrial linoleoyl-coenzyme A monolysocardiolipin acyltransferase (MLCL AT-1)","volume":"284","author":"Taylor WA","year":"2009","unstructured":"Taylor, W. A. & Hatch, G. M. Identification of the human mitochondrial linoleoyl-coenzyme A monolysocardiolipin acyltransferase (MLCL AT-1). J. Biol. Chem. 284, 30360\u201330371. 10.1074\/jbc.M109.048322 (2009).","journal-title":"J. Biol. Chem."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1042\/BST20220603","article-title":"A tail of their own: regulation of cardiolipin and phosphatidylinositol fatty acyl profile by the acyltransferase LCLAT1","volume":"51","author":"Zhang K","year":"2023","unstructured":"Zhang, K., Chan, V., Botelho, R. J. & Antonescu, C. N. A tail of their own: regulation of cardiolipin and phosphatidylinositol fatty acyl profile by the acyltransferase LCLAT1. Biochem. Soc. Trans. 51, 1765\u20131776. 10.1042\/BST20220603 (2023).","journal-title":"Biochem. Soc. Trans."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/CIRCRESAHA.119.315956","article-title":"AAV Gene Therapy Prevents and Reverses Heart Failure in a Murine Knockout Model of Barth Syndrome","volume":"126","author":"Wang S","year":"2020","unstructured":"Wang, S. et al. AAV Gene Therapy Prevents and Reverses Heart Failure in a Murine Knockout Model of Barth Syndrome. Circ. Res. 126, 1024\u20131039. 10.1161\/CIRCRESAHA.119.315956 (2020).","journal-title":"Circ. Res."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/hmg\/ddad041","article-title":"Genetic modifiers modulate phenotypic expression of tafazzin deficiency in a mouse model of Barth syndrome","volume":"32","author":"Wang S","year":"2023","unstructured":"Wang, S. et al. Genetic modifiers modulate phenotypic expression of tafazzin deficiency in a mouse model of Barth syndrome. Hum. Mol. Genet. 32, 2055\u20132067. 10.1093\/hmg\/ddad041 (2023).","journal-title":"Hum. Mol. Genet."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e008289","DOI":"10.1161\/CIRCHEARTFAILURE.121.008289","article-title":"Cardiolipin Remodeling Defects Impair Mitochondrial Architecture and Function in a Murine Model of Barth Syndrome Cardiomyopathy","volume":"14","author":"Zhu S","year":"2021","unstructured":"Zhu, S. et al. Cardiolipin Remodeling Defects Impair Mitochondrial Architecture and Function in a Murine Model of Barth Syndrome Cardiomyopathy. Circ. Heart Fail. 14, e008289. 10.1161\/CIRCHEARTFAILURE.121.008289 (2021).","journal-title":"Circ. Heart Fail."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd3020013","article-title":"Advances in the Study of Heart Development and Disease Using Zebrafish","volume":"3","author":"Brown DR","year":"2016","unstructured":"Brown, D. R., Samsa, L. A., Qian, L. & Liu, J. Advances in the Study of Heart Development and Disease Using Zebrafish. J. Cardiovasc. Dev. Dis. 3 10.3390\/jcdd3020013 (2016).","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/biomedicines7010015","article-title":"On Zebrafish Disease Models and Matters of the Heart","volume":"7","author":"Giardoglou P","year":"2019","unstructured":"Giardoglou, P. & Beis, D. On Zebrafish Disease Models and Matters of the Heart. Biomedicines 7, 15. 10.3390\/biomedicines7010015 (2019).","journal-title":"Biomedicines"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098314","article-title":"Modeling Human Muscular Dystrophies in Zebrafish: Mutant Lines, Transgenic Fluorescent Biosensors, and Phenotyping Assays","volume":"24","author":"Tesoriero C","year":"2023","unstructured":"Tesoriero, C. et al. Modeling Human Muscular Dystrophies in Zebrafish: Mutant Lines, Transgenic Fluorescent Biosensors, and Phenotyping Assays. Int. J. Mol. Sci. 24 10.3390\/ijms24098314 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bbadis.2006.07.003","article-title":"Modeling human muscle disease in zebrafish","volume":"1772","author":"Guyon JR","year":"2007","unstructured":"Guyon, J. R. et al. Modeling human muscle disease in zebrafish. Biochim. Biophys. Acta. 1772, 205\u2013215. 10.1016\/j.bbadis.2006.07.003 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e312","DOI":"10.1002\/wdev.312","article-title":"The zebrafish: A fintastic model for hematopoietic development and disease","volume":"7","author":"Gore AV","year":"2018","unstructured":"Gore, A. V., Pillay, L. M., Venero Galanternik, M. & Weinstein, B. M. The zebrafish: A fintastic model for hematopoietic development and disease. Wiley interdisciplinary reviews Dev. biology. 7, e312. 10.1002\/wdev.312 (2018).","journal-title":"Wiley interdisciplinary reviews Dev. biology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1089\/hum.2016.024","article-title":"Fish to Learn: Insights into Blood Development and Blood Disorders from Zebrafish Hematopoiesis","volume":"27","author":"Avagyan S","year":"2016","unstructured":"Avagyan, S. & Zon, L. I. Fish to Learn: Insights into Blood Development and Blood Disorders from Zebrafish Hematopoiesis. Hum. Gene Ther. 27, 287\u2013294. 10.1089\/hum.2016.024 (2016).","journal-title":"Hum. Gene Ther."},{"key":"ref26","volume-title":"The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Danio Rerio)","author":"Westerfield M","year":"2000","unstructured":"Westerfield, M. The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Danio Rerio) (Institute of Neuroscience. University of Oregon, 2000)."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"W77","DOI":"10.1093\/nar\/gkt439","article-title":"WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013","volume":"41","author":"Wang J","year":"2013","unstructured":"Wang, J., Duncan, D., Shi, Z. & Zhang, B. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res. 41, W77\u201383. 10.1093\/nar\/gkt439 (2013).","journal-title":"Nucleic Acids Res."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"W147","DOI":"10.1093\/nar\/gkw419","article-title":"Heatmapper: web-enabled heat mapping for all","volume":"44","author":"Babicki S","year":"2016","unstructured":"Babicki, S. et al. Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res. 44, W147\u2013153. 10.1093\/nar\/gkw419 (2016).","journal-title":"Nucleic Acids Res."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/jat.3311","article-title":"Triclosan is a mitochondrial uncoupler in live zebrafish","volume":"36","author":"Shim J","year":"2016","unstructured":"Shim, J. et al. Triclosan is a mitochondrial uncoupler in live zebrafish. J. Appl. Toxicol. 36, 1662\u20131667. 10.1002\/jat.3311 (2016).","journal-title":"J. Appl. Toxicol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/978-1-4939-7883-0_21","article-title":"Live Metabolic Profile Analysis of Zebrafish Embryos Using a Seahorse XF 24 Extracellular Flux Analyzer","volume":"1797","author":"Bond ST","year":"2018","unstructured":"Bond, S. T., McEwen, K. A., Yoganantharajah, P. & Gibert, Y. Live Metabolic Profile Analysis of Zebrafish Embryos Using a Seahorse XF 24 Extracellular Flux Analyzer. Methods Mol. Biol. 1797, 393\u2013401. 10.1007\/978-1-4939-7883-0_21 (2018).","journal-title":"Methods Mol. Biol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1477-7827-3-63","article-title":"Zebrafish sex determination and differentiation: involvement of FTZ-F1 genes","volume":"3","author":"Hofsten J","year":"2005","unstructured":"von Hofsten, J. & Olsson, P. E. Zebrafish sex determination and differentiation: involvement of FTZ-F1 genes. Reprod. Biol. Endocrinol. 3, 63. 10.1186\/1477-7827-3-63 (2005).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.reprotox.2011.06.121","article-title":"Zebrafish embryos as an alternative to animal experiments\u2013a commentary on the definition of the onset of protected life stages in animal welfare regulations","volume":"33","author":"Strahle U","year":"2012","unstructured":"Strahle, U. et al. Zebrafish embryos as an alternative to animal experiments\u2013a commentary on the definition of the onset of protected life stages in animal welfare regulations. Reprod. Toxicol. 33, 128\u2013132. 10.1016\/j.reprotox.2011.06.121 (2012).","journal-title":"Reprod. Toxicol."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/metabo9120306","article-title":"Barth Syndrome: Exploring Cardiac Metabolism with Induced Pluripotent Stem Cell-Derived Cardiomyocytes","volume":"9","author":"Fatica EM","year":"2019","unstructured":"Fatica, E. M. et al. Barth Syndrome: Exploring Cardiac Metabolism with Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Metabolites 9 10.3390\/metabo9120306 (2019).","journal-title":"Metabolites"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"11568","DOI":"10.1074\/jbc.RA119.009037","article-title":"Cardiolipin-induced activation of pyruvate dehydrogenase links mitochondrial lipid biosynthesis to TCA cycle function","volume":"294","author":"Li Y","year":"2019","unstructured":"Li, Y. et al. Cardiolipin-induced activation of pyruvate dehydrogenase links mitochondrial lipid biosynthesis to TCA cycle function. J. Biol. Chem. 294, 11568\u201311578. 10.1074\/jbc.RA119.009037 (2019).","journal-title":"J. Biol. Chem."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"12485","DOI":"10.1074\/jbc.RA119.011229","article-title":"Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria","volume":"295","author":"Le CH","year":"2020","unstructured":"Le, C. H. et al. Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria. J. Biol. Chem. 295, 12485\u201312497. 10.1074\/jbc.RA119.011229 (2020).","journal-title":"J. Biol. Chem."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10545-012-9486-x","article-title":"Substrate metabolism during basal and hyperinsulinemic conditions in adolescents and young-adults with Barth syndrome","volume":"36","author":"Cade WT","year":"2013","unstructured":"Cade, W. T. et al. Substrate metabolism during basal and hyperinsulinemic conditions in adolescents and young-adults with Barth syndrome. J. Inherit. Metab. Dis. 36, 91\u2013101. 10.1007\/s10545-012-9486-x (2013).","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4137\/LPI.S31746","article-title":"Greasing the Cholesterol Transport Machinery","volume":"8","author":"Lagace TA","year":"2015","unstructured":"Lagace, T. A. & Phosphatidylcholine Greasing the Cholesterol Transport Machinery. Lipid Insights. 8, 65\u201373. 10.4137\/LPI.S31746 (2015).","journal-title":"Lipid Insights"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20051149","article-title":"An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases","volume":"20","author":"Law SH","year":"2019","unstructured":"Law, S. H. et al. An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases. Int. J. Mol. Sci. 20 10.3390\/ijms20051149 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168468","article-title":"Long-Chain Acyl-Carnitines Interfere with Mitochondrial ATP Production Leading to Cardiac Dysfunction in Zebrafish","volume":"22","author":"Park DD","year":"2021","unstructured":"Park, D. D. et al. Long-Chain Acyl-Carnitines Interfere with Mitochondrial ATP Production Leading to Cardiac Dysfunction in Zebrafish. Int. J. Mol. Sci. 22 10.3390\/ijms22168468 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e0151802","DOI":"10.1371\/journal.pone.0151802","article-title":"Metabolomics Reveals New Mechanisms for Pathogenesis in Barth Syndrome and Introduces Novel Roles for Cardiolipin in Cellular Function","volume":"11","author":"Sandlers Y","year":"2016","unstructured":"Sandlers, Y. et al. Metabolomics Reveals New Mechanisms for Pathogenesis in Barth Syndrome and Introduces Novel Roles for Cardiolipin in Cellular Function. PLoS One. 11, e0151802. 10.1371\/journal.pone.0151802 (2016).","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/iub.2018","article-title":"Mitochondrial dysfunctions in barth syndrome","volume":"71","author":"Ghosh S","year":"2019","unstructured":"Ghosh, S., Iadarola, D. M., Ball, W. B. & Gohil, V. M. Mitochondrial dysfunctions in barth syndrome. IUBMB life. 71, 791\u2013801. 10.1002\/iub.2018 (2019).","journal-title":"IUBMB life"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/15548627.2015.1023984","article-title":"Cardiolipin remodeling by TAZ\/tafazzin is selectively required for the initiation of mitophagy","volume":"11","author":"Hsu P","year":"2015","unstructured":"Hsu, P. et al. Cardiolipin remodeling by TAZ\/tafazzin is selectively required for the initiation of mitophagy. Autophagy 11, 643\u2013652. 10.1080\/15548627.2015.1023984 (2015).","journal-title":"Autophagy"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/molbev\/mss212","article-title":"Whole-genome duplication and the functional diversification of teleost fish hemoglobins","volume":"30","author":"Opazo JC","year":"2013","unstructured":"Opazo, J. C., Butts, G. T., Nery, M. F., Storz, J. F. & Hoffmann, F. G. Whole-genome duplication and the functional diversification of teleost fish hemoglobins. Mol. Biol. Evol. 30, 140\u2013153. 10.1093\/molbev\/mss212 (2013).","journal-title":"Mol. Biol. Evol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/jimd.12423","article-title":"Experimental models of Barth syndrome","volume":"45","author":"Pu WT","year":"2022","unstructured":"Pu, W. T. Experimental models of Barth syndrome. J. Inherit. Metab. Dis. 45, 72\u201381. 10.1002\/jimd.12423 (2022).","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1161\/01.RES.0000233378.95325.ce","article-title":"A zebrafish model of human Barth syndrome reveals the essential role of tafazzin in cardiac development and function","volume":"99","author":"Khuchua Z","year":"2006","unstructured":"Khuchua, Z., Yue, Z., Batts, L. & Strauss, A. W. A zebrafish model of human Barth syndrome reveals the essential role of tafazzin in cardiac development and function. Circ. Res. 99, 201\u2013208. 10.1161\/01.RES.0000233378.95325.ce (2006).","journal-title":"Circ. Res."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.devcel.2014.11.018","article-title":"Reverse genetic screening reveals poor correlation between morpholino-induced and mutant phenotypes in zebrafish","volume":"32","author":"Kok FO","year":"2015","unstructured":"Kok, F. O. et al. Reverse genetic screening reveals poor correlation between morpholino-induced and mutant phenotypes in zebrafish. Dev. Cell. 32, 97\u2013108. 10.1016\/j.devcel.2014.11.018 (2015).","journal-title":"Dev. Cell."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e1006780","DOI":"10.1371\/journal.pgen.1006780","article-title":"Genetic compensation: A phenomenon in search of mechanisms","volume":"13","author":"El-Brolosy MA","year":"2017","unstructured":"El-Brolosy, M. A. & Stainier, D. Y. R. Genetic compensation: A phenomenon in search of mechanisms. PLoS Genet. 13, e1006780. 10.1371\/journal.pgen.1006780 (2017).","journal-title":"PLoS Genet."},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073472","article-title":"Genotype to Phenotype: CRISPR Gene Editing Reveals Genetic Compensation as a Mechanism for Phenotypic Disjunction of Morphants and Mutants","volume":"22","author":"Salanga CM","year":"2021","unstructured":"Salanga, C. M. & Salanga, M. C. Genotype to Phenotype: CRISPR Gene Editing Reveals Genetic Compensation as a Mechanism for Phenotypic Disjunction of Morphants and Mutants. Int. J. Mol. Sci. 22 10.3390\/ijms22073472 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature14580","article-title":"Genetic compensation induced by deleterious mutations but not gene knockdowns","volume":"524","author":"Rossi A","year":"2015","unstructured":"Rossi, A. et al. Genetic compensation induced by deleterious mutations but not gene knockdowns. Nature 524, 230\u2013233. 10.1038\/nature14580 (2015).","journal-title":"Nature"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"e1009088","DOI":"10.1371\/journal.pgen.1009088","article-title":"Genetic compensation prevents myopathy and heart failure in an in vivo model of Bag3 deficiency","volume":"16","author":"Diofano F","year":"2020","unstructured":"Diofano, F. et al. Genetic compensation prevents myopathy and heart failure in an in vivo model of Bag3 deficiency. PLoS Genet. 16, e1009088. 10.1371\/journal.pgen.1009088 (2020).","journal-title":"PLoS Genet."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41586-019-1064-z","article-title":"Genetic compensation triggered by mutant mRNA degradation","volume":"568","author":"El-Brolosy MA","year":"2019","unstructured":"El-Brolosy, M. A. et al. Genetic compensation triggered by mutant mRNA degradation. Nature 568, 193\u2013197. 10.1038\/s41586-019-1064-z (2019).","journal-title":"Nature"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1250772","DOI":"10.3389\/fped.2023.1250772","article-title":"Case report: Variability in clinical features as a potential pitfall for the diagnosis of Barth syndrome","volume":"11","author":"Tovaglieri N","year":"2023","unstructured":"Tovaglieri, N., Russo, S., Micaglio, E., Corcelli, A. & Lobasso, S. Case report: Variability in clinical features as a potential pitfall for the diagnosis of Barth syndrome. Front. Pediatr. 11, 1250772. 10.3389\/fped.2023.1250772 (2023).","journal-title":"Front. Pediatr."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ymgme.2012.09.013","article-title":"Intrafamilial variability for novel TAZ gene mutation: Barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle","volume":"107","author":"Ronvelia D","year":"2012","unstructured":"Ronvelia, D., Greenwood, J., Platt, J., Hakim, S. & Zaragoza, M. V. Intrafamilial variability for novel TAZ gene mutation: Barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle. Mol. Genet. Metab. 107, 428\u2013432. 10.1016\/j.ymgme.2012.09.013 (2012).","journal-title":"Mol. Genet. Metab."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jpeds.2017.09.075","article-title":"Barth Syndrome: Different Approaches to Diagnosis","volume":"193","author":"Imai-Okazaki A","year":"2018","unstructured":"Imai-Okazaki, A. et al. Barth Syndrome: Different Approaches to Diagnosis. J. Pediatr. 193, 256\u2013260. 10.1016\/j.jpeds.2017.09.075 (2018).","journal-title":"J. Pediatr."},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.08.005","author":"Riffelmacher T","year":"2017","unstructured":"Riffelmacher, T. et al. Autophagy-Dependent Generation of Free Fatty Acids Is Critical for Normal Neutrophil Differentiation. Immunity 47, 466\u2013480 e465, (2017). 10.1016\/j.immuni.2017.08.005"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41423-020-00608-1","article-title":"Interleukin-6 mediates neutrophil mobilization from bone marrow in pulmonary hypertension","volume":"18","author":"Florentin J","year":"2021","unstructured":"Florentin, J. et al. Interleukin-6 mediates neutrophil mobilization from bone marrow in pulmonary hypertension. Cell. Mol. Immunol. 18, 374\u2013384. 10.1038\/s41423-020-00608-1 (2021).","journal-title":"Cell. Mol. Immunol."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5960642\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5960642\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T16:25:48Z","timestamp":1751905548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5960642\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":56,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-5960642\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41598-025-07843-4","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,4,24]]},"subtype":"preprint"}}